Gut microbiota

PreclinicalBiologic

SShanghai Jiao Tong University School of Medicine

Gut microbiota is one of 58 biologic programs targeting Colorectal Cancer. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Colorectal CancerActive, not recruiting

SarcopeniaActive, not recruiting

Colorectal CancerPreclinical

Active, not recruiting

SarcopeniaPreclinical

Active, not recruiting

Competition

Competitive Landscape

254 competitors in Colorectal Cancer

#DrugCompanyPhaseTrials

XL092

Roche

Phase 3

1 2

TAS 102

Taiho Oncology, Inc.

Phase 3

8 3

Huaier Granule

QQidong Gaitianli Medicines Co., Ltd

Phase 3

4 4

5-Fu

TToray Industries, Inc

Phase 3

4 5

PD-1 Monoclonal Antibody

SSichuan Baili Pharmaceutical Co., Ltd.

Phase 3

2 6

IBI363

Innovent Biologics (Suzhou) Co. Ltd.

Phase 3

1 7

BL-M07D1

SSichuan Baili Pharmaceutical Co., Ltd.

Phase 3

1 8

TQB2102

CChia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

Phase 3

1 9

Calcium Levofolinate

FFujian Cancer Hospital

Phase 3

1 10

HR070803

JJiangsu HengRui Medicine Co., Ltd.

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Gut Microbiota2 trials

Gut Microbiota Pilot Study

Unknown status·—··NCT03892590·40 enrolled

Gut Microbiota Pilot Study

Unknown status·TThe Catholic University of Korea··NCT03897023·40 enrolled

Sarcopenia1 trial

Sarcopenia and Nutritional Status in a Rehabilitation Setting

Recruiting·FFondazione Don Carlo Gnocchi Onlus··NCT04791540·30 enrolled

Colorectal Cancer1 trial

Study of Fecal Bacteria in Early Diagnosis of Colorectal Cancer

Completed·SShanghai Jiao Tong University School of Medicine··NCT02845973·1,325 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Gut microbiota. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Gut microbiota compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Gut microbiota. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Shanghai Jiao Tong University School of Medicine company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: SShanghai Jiao Tong University School of Medicine

Gut microbiota

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Gut Microbiota2 trials

Sarcopenia1 trial

Colorectal Cancer1 trial

References

Drug Info

Quick Facts

Related News